
Outside of the two most common blood cancer categories, leukemia and lymphoma, there are other blood cancers that we research.
Examples of additional blood cancers include essential thrombocythemia and multiple myeloma.

Merck & Co, Inc, Rahway, NJ, USA, known as MSD outside of the United States and Canada, provides international versions of this site for both healthcare professionals and the general public.
Select a language below to be redirected to the MSD version of the site in your chosen language.
Latin America
Europe
Asia Pacific
Australia
Africa

Additional Blood Cancers
Examples of additional blood cancers include essential thrombocythemia and multiple myeloma.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Below is a list of available additional blood cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can also sort results to show trials nearest to you by entering your city and state in the search field.

